Blood RNA alternative splicing events as diagnostic biomarkers for infectious disease

Abstract

Assays detecting blood transcriptome changes are studied for infectious disease diagnosis. Blood-based RNA alternative splicing (AS) events, which have not been well characterized in pathogen infection, have potential normalization and assay platform stability advantages over gene expression for diagnosis. Here, we present a computational framework for developing AS diagnostic biomarkers. Leveraging a large prospective cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and whole-blood RNA sequencing (RNA-seq) data, we identify a major functional AS program switch upon viral infection. Using an independent cohort, we demonstrate the improved accuracy of AS biomarkers for SARS-CoV-2 diagnosis compared with six reported transcriptome signatures. We then optimize a subset of AS-based biomarkers to develop microfluidic PCR diagnostic assays. This assay achieves nearly perfect test accuracy (61/62 = 98.4%) using a naive principal component classifier, significantly more accurate than a gene expression PCR assay in the same cohort. Therefore, our RNA splicing computational framework enables a promising avenue for host-response diagnosis of infection.

Department

Description

Provenance

Subjects

Citation

Published Version (Please cite this version)

10.1016/j.crmeth.2023.100395

Publication Info

Zhang, Zijun, Natalie Sauerwald, Antonio Cappuccio, Irene Ramos, Venugopalan D Nair, German Nudelman, Elena Zaslavsky, Yongchao Ge, et al. (2023). Blood RNA alternative splicing events as diagnostic biomarkers for infectious disease. Cell Reports Methods. pp. 100395–100395. 10.1016/j.crmeth.2023.100395 Retrieved from https://hdl.handle.net/10161/26731.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.